Literature DB >> 16857668

Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling.

Rebecca J Gibbard1, Peter J Morley, Nicholas J Gay.   

Abstract

Toll-like receptor (TLR) 8 has an important role in initiating immune responses to viral single-stranded RNA and the antiviral compound resiquimod. Together with TLR3, -7, and -9, it forms a subgroup of the TLRs that are localized intracellularly and signal in response to pathogen-derived nucleic acids. In this work, we have used site-directed mutagenesis to identify regions of the TLR8 extracellular domain that are required for stimulus-induced signal transduction. We have shown that a cysteinerich sequence predicted to form a loop projecting from the solenoidal ectodomain structure at leucine-rich repeat 8 is essential for signaling in response to both single-stranded RNA and resiquimod. A second region, centered on an aspartic acid residue in leucine-rich repeat 17, is also required for TLR8 function. The corresponding residue in TLR9 is known to be important for pH-dependent binding and signaling in response to unmethylated CpG DNA, suggesting that the TLR7/8/9 subgroups share a common signaling mechanism. We have also shown that TLR8 is localized predominantly in the endoplasmic reticulum but that signaling is completely abolished by an inhibitor of vesicle-type H+ ATPases. This indicates that TLR8 is present at low levels in an acidified compartment and that a lowered pH is required for receptor function. We propose that pH-dependent changes in the ligand facilitate activation of the receptor. The protonated form of resiquimod, a cell-permeable weak base, is likely to concentrate significantly (approximately 100x) in acidified compartments, and this may potentiate low affinity interactions with either the receptor or a specific binding protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857668     DOI: 10.1074/jbc.M605003200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains.

Authors:  Andriy V Kubarenko; Satish Ranjan; Elif Colak; Julie George; Martin Frank; Alexander N R Weber
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

2.  Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains.

Authors:  Tiandi Wei; Jing Gong; Ferdinand Jamitzky; Wolfgang M Heckl; Robert W Stark; Shaila C Rössle
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

Review 3.  International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease.

Authors:  Clare E Bryant; Selinda Orr; Brian Ferguson; Martyn F Symmons; Joseph P Boyle; Tom P Monie
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 4.  Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

Authors:  Jing Li; Xiaohui Wang; Fengchun Zhang; Hang Yin
Journal:  Pharmacol Ther       Date:  2013-03-24       Impact factor: 12.310

Review 5.  Assembly and localization of Toll-like receptor signalling complexes.

Authors:  Nicholas J Gay; Martyn F Symmons; Monique Gangloff; Clare E Bryant
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

6.  A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains.

Authors:  Tiandi Wei; Jing Gong; Shaila C Rössle; Ferdinand Jamitzky; Wolfgang M Heckl; Robert W Stark
Journal:  J Mol Model       Date:  2010-03-30       Impact factor: 1.810

7.  A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition.

Authors:  Jin Liu; Congfeng Xu; Li-Chung Hsu; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Mol Immunol       Date:  2009-12-08       Impact factor: 4.407

8.  A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

Authors:  Andriy V Kubarenko; Satish Ranjan; Anna Rautanen; Tara C Mills; Sunny Wong; Fredrik Vannberg; Michael Neumaier; Isabelle Bekeredjian-Ding; Adrian V S Hill; Parviz Ahmad-Nejad; Alexander N R Weber
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

9.  Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like receptor signaling.

Authors:  Rajiv Gandhi Govindaraj; Balachandran Manavalan; Gwang Lee; Sangdun Choi
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

10.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.